Dashboard
Manage Tickers

CUE


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/09/2025 21:06:16

lucid-capital-markets-initiates-coverage-on-cue-biopharma-with-buy-rating-announces-price-target-of-4
LUCID CAPITAL MARKETS Initiates Coverage O...
08/25/2025 17:27:53

LUCID CAPITAL MARKETS analyst Dev Prasad initiates coverage on Cue Biopharma (NASDAQ:CUE) with a Buy rating and announces P...

cue-biopharma-initiates-investigator-sponsored-trial-of-cue-102-for-recurrent-glioblastoma-multiforme
Cue Biopharma Initiates Investigator Spons...
08/13/2025 12:09:02

cue-biopharma-q2-eps-009-beats-014-estimate-sales-2954m-beat-2396m-estimate
Cue Biopharma Q2 EPS $(0.09) Beats $(0.14)...
08/12/2025 20:33:23

Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.14) ...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/16/2025 21:06:00

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/16/2025 17:06:26

reported-earlier-cue-biopharma-reports-50-overall-response-rate-and-88-12-month-survival-in-cue-101-trial-for-hpv-cancers
Reported Earlier: Cue Biopharma Reports 50...
07/16/2025 16:06:52

Additional complete response (CR) observed in patient with multiple tumorsConfirmed overall response rate (ORR) of 50% in patie...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/01/2025 21:05:47

cue-biopharma-issues-update-on-its-clinical-stage-asset-cue-101-representative-of-cue-100-series-data-highlights-include-orr-of-50-in-treatment-naive-patients-with-hpv-rm-hnscc
Cue Biopharma Issues Update On Its Clinica...
07/01/2025 20:08:30

ORR of 50% in treatment-naïve patients with HPV+ R/M HNSCC12-month landmark survival of 88% and mOS of 32 monthsBOSTON, July 01...

cue-biopharma-receives-fda-pre-ind-feedback-for-lead-autoimmune-therapy-cue-401-plans-ind-filing-pending-final-studies
Cue Biopharma Receives FDA Pre-IND Feedbac...
06/24/2025 20:50:01

Cue Biopharma, Inc. (NASDAQ:CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics ...

cue-biopharma-ceo-daniel-passeri-to-serve-as-interim-cfo-kerri-ann-millar-resigns-as-cfo
Cue Biopharma CEO Daniel Passeri To Serve ...
06/10/2025 20:05:08

 - SEC Filing

cue-biopharma-q1-eps-017-misses-015-estimate-sales-42100k-miss-127m-estimate
Cue Biopharma Q1 EPS $(0.17) Misses $(0.15...
05/12/2025 20:49:12

Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.15...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/15/2025 21:05:49

reported-earlier-cue-biopharma-prices-20m-public-offering-of-common-stock-and-warrants-at-079
Reported Earlier, Cue Biopharma Prices $20...
04/15/2025 06:31:04

cue-biopharma-announces-proposed-public-offering-no-size-or-amount-disclosed
Cue Biopharma Announces Proposed Public Of...
04/14/2025 21:06:35

Cue Biopharma, Inc. (NASDAQ:CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics ...

cue-biopharma-and-boehringer-ingelheim-announce-strategic-partnership-to-develop-and-commercialize-first-in-class-bispecific-t-cell-engaging-b-cell-depletion-therapy-cue-501-for-autoimmune-and-inflammatory-diseases-aiming-for-earlier-intervention-and-long-term-disease-control
Cue Biopharma And Boehringer Ingelheim Ann...
04/14/2025 21:03:20

Partnership bolsters Boehringer's autoimmune and inflammatory disease pipeline portfolio aiming to tackle areas of high unm...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
04/07/2025 12:08:52

citizens-capital-markets-reiterates-market-outperform-on-cue-biopharma-maintains-2-price-target
Citizens Capital Markets Reiterates Market...
04/02/2025 15:07:04

Citizens Capital Markets analyst Reni Benjamin reiterates Cue Biopharma (NASDAQ:CUE) with a Market Outperform and maintains ...

whats-going-on-with-cue-biopharma-shares-tuesday
What's Going On With Cue Biopharma Shares ...
04/01/2025 16:14:03

Cue reported 2024 fiscal-year earnings on Monday after the market closed.

cue-biopharma-fy24-eps-072-up-from-111-yoy-revenue-9287m-up-from-5490m-yoy
Cue Biopharma FY24 EPS ($0.72) Up From ($1...
03/31/2025 20:27:39

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION